长期抗逆转录病毒治疗后克隆性更替使针对 HIV-1 的 CD8 T 细胞反应恢复活力。

Clonal succession after prolonged antiretroviral therapy rejuvenates CD8 T cell responses against HIV-1.

机构信息

ImmunoConcEpT, UMR 5164, Université de Bordeaux, CNRS, INSERM, Bordeaux, France.

Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, INSERM, Paris, France.

出版信息

Nat Immunol. 2024 Sep;25(9):1555-1564. doi: 10.1038/s41590-024-01931-9. Epub 2024 Aug 23.

Abstract

Human immunodeficiency virus 1 (HIV-1) infection is characterized by a dynamic and persistent state of viral replication that overwhelms the host immune system in the absence of antiretroviral therapy (ART). The impact of prolonged treatment on the antiviral efficacy of HIV-1-specific CD8 T cells has nonetheless remained unknown. Here, we used single-cell technologies to address this issue in a cohort of aging individuals infected early during the pandemic and subsequently treated with continuous ART. Our data showed that long-term ART was associated with a process of clonal succession, which effectively rejuvenated HIV-1-specific CD8 T cell populations in the face of immune senescence. Tracking individual transcriptomes further revealed that initially dominant CD8 T cell clonotypes displayed signatures of exhaustion and terminal differentiation, whereas newly dominant CD8 T cell clonotypes displayed signatures of early differentiation and stemness associated with natural control of viral replication. These findings reveal a degree of immune resilience that could inform adjunctive treatments for HIV-1.

摘要

人类免疫缺陷病毒 1(HIV-1)感染的特征是病毒复制的动态和持续状态,在没有抗逆转录病毒疗法(ART)的情况下,这种状态会使宿主免疫系统不堪重负。然而,长期治疗对 HIV-1 特异性 CD8 T 细胞的抗病毒疗效的影响仍不清楚。在这里,我们使用单细胞技术来解决这一问题,该技术针对的是在大流行期间早期感染并随后接受持续 ART 治疗的一组老年个体。我们的数据表明,长期的 ART 治疗与克隆连续过程有关,该过程有效地恢复了 HIV-1 特异性 CD8 T 细胞群体的免疫衰老。跟踪单个转录组进一步表明,最初占主导地位的 CD8 T 细胞克隆型表现出衰竭和终末分化的特征,而新占主导地位的 CD8 T 细胞克隆型表现出与病毒复制自然控制相关的早期分化和干细胞特征。这些发现揭示了一定程度的免疫弹性,这可能为 HIV-1 的辅助治疗提供信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索